Treatment Protocols DSIP therapy at Strong Health follows a structured clinical approach: Sleep assessment: Thorough evaluation of sleep patterns, sleep hygiene practices, medical history, and current medications Baseline metrics: Sleep questionnaires, and when indicated, referral for sleep studies to rule out sleep apnea or other primary sleep disorders Protocol design: Physician determines DSIP dosing, timing, and whether combination with other peptides is appropriate Administration: DSIP is typically administered via subcutaneous injection in the evening, 12 hours before desired sleep onset Monitoring: Regular follow-ups to assess sleep quality improvements, adjust dosing, and track any side effects Sleep hygiene integration: Peptide therapy is combined with evidence-based sleep hygiene recommendations for optimal results Safety and Side Effects DSIP has a generally favorable safety profile based on available clinical data
tHcy is considered the best metabolic marker of cobalamin status in infants and toddlers and a plasma tHcy cut-off level of 6.5 mol/L has been suggested for defining cobalamin deficiency in this age-group (Bjrke-Monsen et al., 2008)
SLC25A39 as well as mitochondrial GSH may also represent promising drug targets for cancer, since manipulating SLC25A39 functioning or mitochondrial GSH in tumor cells may induce selective oxidative stress, leading to cell death
Semaglutide is currently approved only as a weekly injection under the skin or as an oral tablet
Myers Cocktail PLUS $290 Enhanced Recovery for Chronic Stress & Advanced Symptoms The Myers Cocktail PLUS is an upgraded version of the original formula ideal for clients dealing with more complex or chronic conditions
